Invention Grant
US07825090B2 Use of ghrelin and unacylated ghrelin compositions for treating insulin resistance
有权
使用生长素释放肽和未分解的生长素释放肽组合物治疗胰岛素抵抗
- Patent Title: Use of ghrelin and unacylated ghrelin compositions for treating insulin resistance
- Patent Title (中): 使用生长素释放肽和未分解的生长素释放肽组合物治疗胰岛素抵抗
-
Application No.: US10595485Application Date: 2004-10-22
-
Publication No.: US07825090B2Publication Date: 2010-11-02
- Inventor: Ezio Ghigo , Aart Jan Van Der Lely
- Applicant: Ezio Ghigo , Aart Jan Van Der Lely
- Applicant Address: FR Ste-Foy-les-Lyons
- Assignee: Alizé Pharma SAS
- Current Assignee: Alizé Pharma SAS
- Current Assignee Address: FR Ste-Foy-les-Lyons
- Agency: Wilmer Cutler Pickering Hale and Dorr LLP
- International Application: PCT/CA2004/001858 WO 20041022
- International Announcement: WO2005/039624 WO 20050506
- Main IPC: A61K38/00
- IPC: A61K38/00
Abstract:
A novel combination of ghrelin and unacylated ghrelin is described herein. Methods of administering and uses of this combination to alter an insulin-associated parameter are also described. Compositions and packages containing ghrelin and/or one of its analogs and nonacylated ghrelin and/or one of its analogs as well as the uses of such compositions in providing therapeutic benefit to human patients diagnosed with for example insulin resistance, diabetes and obesity are described.
Public/Granted literature
- US20080261872A1 Use of Ghrelin and Unacylated Ghrelin Compositions in Insulin-Related Disease Conditions Public/Granted day:2008-10-23
Information query
IPC分类:
